Bath & Body Works, Inc. (NYSE:BBWI) Receives $43.13 Average Target Price from Analysts

Shares of Bath & Body Works, Inc. (NYSE:BBWIGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the sixteen analysts that are currently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $43.13.

A number of research firms have recently issued reports on BBWI. Wells Fargo & Company dropped their price target on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 24th. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research note on Tuesday, August 20th. UBS Group reduced their price target on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Robert W. Baird dropped their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Finally, Piper Sandler reduced their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th.

Check Out Our Latest Stock Analysis on BBWI

Insider Buying and Selling

In related news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.27% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in BBWI. First Community Trust NA purchased a new stake in shares of Bath & Body Works during the 2nd quarter worth approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt grew its stake in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after buying an additional 900 shares in the last quarter. EntryPoint Capital LLC increased its holdings in shares of Bath & Body Works by 224.0% in the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after buying an additional 1,017 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Bath & Body Works by 65.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock valued at $72,000 after buying an additional 730 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Bath & Body Works by 23.4% in the 2nd quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after acquiring an additional 524 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $28.92 on Wednesday. The firm has a market cap of $6.34 billion, a price-to-earnings ratio of 7.00, a price-to-earnings-growth ratio of 0.92 and a beta of 1.77. The business has a 50-day simple moving average of $30.16 and a two-hundred day simple moving average of $37.42. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, research analysts predict that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.77%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

About Bath & Body Works

(Get Free Report

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read More

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.